Table 2 The 66 clinical biomarkers routinely measured in the Qatar Biobank pilot study
Group | Variable |
|---|---|
Bone and joint markers | Calcium |
| Â | Phosphorus |
| Â | Uric acid |
| Â | Vitamin D |
Coagulation tests | Activated partial thromboplastin time |
| Â | Fibrinogen level |
| Â | International normalized ratio |
| Â | Prothrombin time |
Diabetes related tests | C-Peptide |
| Â | Glucose |
| Â | Glycated Haemoglobin A1c % |
| Â | Insulin |
Differential white cell count | Basophil |
| Â | Basophil % |
| Â | Eosinophils |
| Â | Eosinophils % |
| Â | Lymphocytes |
| Â | Lymphocytes % |
| Â | Monocyte |
| Â | Monocyte % |
| Â | Neutrophils |
| Â | Neutrophils % |
| Â | White blood cell |
Electrolytes and renal function tests | Chloride |
Serum creatinine | |
Bicarbonate | |
| Â | Potassium |
| Â | Sodium |
| Â | Urea nitrogen |
Full blood count | Haematocrit |
| Â | Haemoglobin |
| Â | Mean corpuscular haemoglobin |
| Â | Mean corpuscular HGB concentration |
| Â | Mean corpuscular volume |
| Â | Mean platelet volume |
| Â | Platelets |
| Â | Red blood cell |
Sex steroid hormones | Estradiol |
| Â | Sex hormone binding globulin |
| Â | Testosterone |
Inflammation/Autoimmune | Rheumatoid factor |
C-Reactive protein | |
Lipid profile | Cholesterol |
| Â | High density lipoprotein |
| Â | Low density lipoprotein |
| Â | Triglycerides |
Liver function tests | Albumin |
| Â | Alkaline phosphatase |
| Â | Alanine transaminase |
| Â | Aspartate transaminase |
| Â | Gamma glutamyl transferase |
| Â | Total bilirubin |
| Â | Total protein |
Minerals | Iron |
| Â | Ferritin |
| Â | Magnesium |
| Â | Total Iron binding capacity |
Muscle markers | Creatine kinase |
| Â | Myoglobin |
Thyroid function tests | Free triiodothyronine |
| Â | Free thyroxine |
| Â | Thyroid stimulating hormone |
Vitamins | Vitamin B12 |
| Â | Folate serum |
Other tests | Homocysteine |
| Â | N-terminal brain-type natriuretic peptide |